- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- May 2024
- 137 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- March 2024
- 159 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- February 2022
- 35 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- January 2024
- 116 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Carvedilol is a medication used to treat high blood pressure, heart failure, and other cardiovascular conditions. It belongs to a class of drugs known as beta blockers, which work by blocking the action of certain hormones in the body that can cause blood vessels to constrict. Carvedilol is also used to reduce the risk of death after a heart attack. It is available in both immediate-release and extended-release formulations.
Carvedilol is a widely used medication in the cardiovascular drug market. It is often prescribed as a first-line treatment for high blood pressure and heart failure, and is also used to reduce the risk of death after a heart attack. It is generally well-tolerated and has few side effects.
Some companies in the Carvedilol market include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more